Ansun BioPharma, Inc.

Myriad clinical trials are planned or are already under way around the world as pharma and biotech companies, universities and research organizations turn their focus to trying to find treatments for

The Biotechnology Innovation Organization (BIO) has submitted comments to the US Department of the Treasury about proposed foreign investment regulations that the trade group believes will prevent for

Novartis To Target COVID-19 Cytokine Storm With Jakavi Novartis AG is to launch a Phase III trial of Jakavi (ruxolitinib) to treat cytokine storm, the severe immune overreaction seen in some COVID-1

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar